Standout Papers

Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised... 2016 2026 2019 2022 362
  1. Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial (2016)
    Peter M. Villiger, Sabine Adler et al. The Lancet

Immediate Impact

2 from Science/Nature 73 standout
Sub-graph 1 of 22

Citing Papers

Forecasting the Burden of Cardiovascular Disease and Stroke in the United States Through 2050—Prevalence of Risk Factors and Disease: A Presidential Advisory From the American Heart Association
2024 Standout
Rheumatoid arthritis: pathogenesis and therapeutic advances
2024 Standout
17 intermediate papers

Works of Felix Wermelinger being referenced

Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial
2016 Standout
Rapid induction of remission in large vessel vasculitis by IL-6 blockade
2011

Author Peers

Author Last Decade Papers Cites
Felix Wermelinger 409 441 171 8 588
Kent A. Huston 323 430 100 8 583
K Vorpahl 381 495 163 8 680
E. Christiaan Hagen 173 530 193 12 649
Elaine Novakovich 345 502 89 13 588
Patrick Liang 368 441 38 16 680
Josep Angel Bosch-Gil 230 269 77 14 535
B E Pottinger 209 403 124 10 712
Marlène Garrido 240 248 60 12 653
H Kraft 324 385 66 7 517
Margaret A. Viss 167 527 179 11 634

All Works

Loading papers...

Rankless by CCL
2026